Author:
Majeed Fatima,Saleem Javeria,Ullah Kifayat,Rafique Shamsa,Mehar Javaid Bukhari Gul,Dilnawaz Aimen,Tariq Ali,Shahbaz Ferheen
Abstract
The average lifespan of people suffering from HIV-AIDS is estimated to be 9 to 11 years, with Vitamin D deficiency as one of the most common phenomena among them. Anti-Retroviral Therapy (ART) could significantly enhance the quality of life of HIV-AIDS patients; however, it further decreases Vitamin D serum levels among them. Objectives: To evaluate the impact of vitamin D supplementation on immune function, viral load, and other health outcomes in HIV-positive individuals. Methods: This was a descriptive study conducted on a sample of 95 HIV-diagnosed patients aged 19 to 50 years in Punjab, Pakistan. Patients were selected from an AIDS control clinic and prescribed antiretroviral therapy. Baseline assessments were conducted using a structured evaluation questionnaire, and biochemical results were used to classify vitamin D deficiency. Results: The study presents information on PCR viral load counts in HIV patients, including minimum (50), and maximum (750,000) values, mean (32,475) with standard deviation (155,343), 5% sheared mean (28), and the 95% confidence interval (17,802 to 47,148) for the average. Results showed that HIV-positive patients taking vitamin D supplementation had a lower mean rank (50.07) compared to those not taking supplements (57.00), with a difference of 275.5 in the sum of ranks between the two groups. Inferential statistics suggested that vitamin D plays a significant role in improving the prognosis of HIV patients taking ART, with a significance value of 0.0032. Conclusion: The present study concludes that Vitamin D supplementation has a significant role in improving the life status of HIV patients.
Publisher
CrossLinks International Publishers
Reference20 articles.
1. 1. Dawson-Hughes B. Patient education: Vitamin D deficiency (Beyond the Basics). 2021. [Last cited: 20th Mar 2023]. Available at: https://www.uptodate.com/contents/vitamin-d-deficiency-beyond-the-basics.
2. 2. Weinberg M and Schambelan M. Bone and calcium disorders in patients with HIV. 2023. [Last cited: 20th Mar 2023]. Available at: https://www.uptodate.com/contents/bone-and-calcium-disorders-in-patients-with-hiv/print.
3. 3. HIV.gov. What are HIV and AIDS. 2023. [Last cited: 20th Mar 2023]. Available at: https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids/.
4. 4. Steenhoff AP, Schall JI, Samuel J, Seme B, Marape M, Ratshaa B, et al. Vitamin D₃ supplementation in Batswana children and adults with HIV: a pilot double blind randomized controlled trial. PloS One. 2015 Feb; 10(2): e0117123. doi: 10.1371/journal.pone.0117123.
5. 5. Coussens AK, Naude CE, Goliath R, Chaplin G, Wilkinson RJ, Jablonski NG. High-dose vitamin D3 reduces deficiency caused by low UVB exposure and limits HIV-1 replication in urban Southern Africans. Proceedings of the National Academy of Sciences. 2015 Jun; 112(26): 8052-7. doi: 10.1073/pnas.1500909112.